The Canadian Press on MSN5h
Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, Mounjaro
A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes ...
Indianapolis Business Journal6h
The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution
At least 14 states already cover the cost of GLP-1 medications for obesity treatment for patients on Medicaid. Indiana is not ...
Notable healthcare headlines of the week: Becton, Dickinson, Grifols, Eli Lilly and J&J in focus
U.S. President Donald Trump’s tariff announcements and the countermeasures declared by trade partners dominated the week, hitting Wall Street stocks to mark historic declines. The S&P 500 index was ...
3 Dividend Stocks to Buy and Hold for the Next Decade
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Knowridge Science Report13h
New drug can reduce hidden heart attack risk by over 90%
A new drug called lepodisiran may offer hope to millions of people at risk of heart attacks and strokes by targeting a little ...
Cheaper weight loss drugs would boost economy: study
The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?